Use of telemedicine technologies in the management of infectious diseases: A review

Clinical Infectious Diseases

Volumn 60, Issue 7, 2015, Pages 1084-1094

  Parmar, Parmvir ^a   Mackie, David ^b   Varghese, Sunil ^b   Cooper, Curtis ^a,b,c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

hepatitis C virus; HIV; infectious diseases; telemedicine; tuberculosis

Indexed keywords

ANTIVIRAL THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION CONTROL; LUNG TUBERCULOSIS; PATIENT SATISFACTION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; TELEMEDICINE; COMMUNICABLE DISEASES; PROCEDURES;

COMMUNICABLE DISEASES; HUMANS; TELEMEDICINE;

EID: 84926648768     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu1143     Document Type: Article

References (37)

1. Lloyd AR, Clegg J, Lange J, et al. Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting. Clin Infect Dis 2013; 56:1078-84.
2. Nazareth S, Kontorinis N, Muwanwella N, Hamilton A, Leembruggen N, ChengWS. Successful treatment of patients with hepatitis C in rural and remote Western Australia via telehealth. J Telemed Telecare 2013; 19:101-6.
3. Rossaro L, Aoki C, Yuk J, Prosser C, Goforth J, Martinez F. The evaluation of patients with hepatitis C living in rural California via telemedicine. Telemed J E Health 2008; 14:1127-9.
4. Rossaro L, Torruellas C, Dhaliwal S, et al. Clinical outcomes of hepatitis C treated with pegylated interferon and ribavirin via telemedicine consultation in northern California. Dig Dis Sci 2013; 58:3620-5.
5. Yawn BP, Wollan P, Gazzuola L, Kim WR. Diagnosis and 10-year follow-up of a community-based hepatitis C cohort. J Fam Pract 2002; 51:135-40.
6. You A, Kawamoto J, Smith JP. A pharmacist-managed telemedicine clinic for hepatitis C care: a descriptive analysis. J Telemed Telecare 2014; 20:99-101.
7. Young JD, Patel M, Badowski M, et al. Improved virologic suppression with HIV subspecialty care in a large prison system using telemedicine: an observational study with historical controls. Clin Infect Dis 2014; 59:123-6.
8. Arora S, Thornton K, Jenkusky SM, Parish B, Scaletti JV. Project ECHO: linking university specialists with rural and prison-based clinicians to improve care for people with chronic hepatitis C in New Mexico. Public Health Rep 2007; 122(suppl 2):74-7.
9. Arora S, Thornton K, Murata G, et al. Outcomes of treatment for hepatitis C virus infection by primary care providers. N Engl J Med 2011; 364:2199-207.
10. DeMaio J, Schwartz L, Cooley P, Tice A. The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project. Clin Infect Dis 2001; 33:2082-4.
11. DeMaio J, Sharma D. Tuberculosis therapy and telemedicine. Expert Opin Pharmacother 2002; 3:1283-8.
12. Gassanov MA, Feldman LJ, Sebastian A, Kraguljac MJ, Rea E, Yaffe B. The use of videophone for directly observed therapy for the treatment of tuberculosis. Can J Public Health 2013; 104:e272.
13. Khatri K, Haddad M, Anderson D. Project ECHO: replicating a novel model to enhance access to hepatitis C care in a community health center. J Health Care Poor Underserved 2013; 24:850-8.
14. Rossaro L, Tran TP, Ransibrahmanakul K, et al. Hepatitis C videoconferencing: the impact on continuing medical education for rural healthcare providers. Telemed J E Health 2007; 13:269-77.
15. Saifu HN, Asch SM, Goetz MB, et al. Evaluation of human immunodeficiency virus and hepatitis C telemedicine clinics. Am J Manag Care 2012; 18:207-12.
16. Wade VA, Karnon J, Eliott JA, Hiller JE. Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluation. PLoS One 2012; 7:e50155.
17. Elbert NJ, van Os-Medendorp H, van Renselaar W, et al. Effectiveness and cost-effectiveness of ehealth interventions in somatic diseases: a systematic review of systematic reviews and meta-Analyses. J Med Internet Res 2014; 16:e110.
18. Eron L. Telemedicine: the future of outpatient therapy?. Clin Infect Dis 2010; 51(suppl 2):S224-30.
19. Leon A, Caceres C, Fernandez E, et al. A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized study. PLoS One 2011; 6:e14515.
20. Gennai S, Francois P, Sellier E, Vittoz JP, Hincky-Vitrat V, Pavese P. Prospective study of telephone calls to a hotline for infectious disease consultation: analysis of 7, 863 solicited consultations over a 1-year period. Eur J Clin Microbiol Infect Dis 2011; 30:509-14.
21. Eron L, King P, Marineau M, Yonehara C. Treating acute infections by telemedicine in the home. Clin Infect Dis 2004; 39:1175-81.
22. dos Santos RP, Deutschendorf C, Carvalho OF, Timm R, Sparenberg A. Antimicrobial stewardship through telemedicine in a community hospital in Southern Brazil. J Telemed Telecare 2013; 19:1-4.
23. Assimacopoulos A, Alam R, Arbo M, et al. A brief retrospective review of medical records comparing outcomes for inpatients treated via telehealth versus in-person protocols: is telehealth equally effective as inperson visits for treating neutropenic fever, bacterial pneumonia, and infected bacterial wounds?. Telemed J E Health 2008; 14:762-8.
24. Dougherty JP, Lipman TH, Hyams S, Montgomery KA. Telemedicine for adolescents with type 1 diabetes.West J Nurs Res 2014; 36:1199-221.
25. Giordano A, Scalvini S, Paganoni AM, et al. Home-based telesurveillance program in chronic heart failure: effects on clinical status and implications for 1-year prognosis. Telemed J E Health 2013; 19:605-12.
26. Goldstein RS, O'Hoski S. Telemedicine in COPD: time to pause. Chest 2014; 145:945-9.
27. Rho MJ, Kim SR, Kim HS, et al. Exploring the relationship among user satisfaction, compliance, and clinical outcomes of telemedicine services for glucose control. Telemed J E Health 2014; 20:712-20.
28. Schou L, Ostergaard B, Rasmussen LS, et al. Telemedicine-based treatment versus hospitalization in patients with severe chronic obstructive pulmonary disease and exacerbation: effect on cognitive function. A randomized clinical trial. Telemed J E Health 2014; 20:640-6.
29. Xiang R, Li L, Liu SX. Meta-Analysis and meta-regression of telehealth programmes for patients with chronic heart failure. J Telemed Telecare 2013; 19:249-59.
30. Gale HB, Gitterman SR, Hoffman HJ, et al. Is frequent CD4+ Tlymphocyte count monitoring necessary for persons with counts =300 cells/μL and HIV-1 suppression?. Clin Infect Dis 2013; 56:1340-3.
31. Reekie J, Mocroft A, Sambatakou H, et al. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?. AIDS 2008; 22:2381-90.
32. Ayoub WS, Keeffe EB. Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther 2011; 34:1145-58.
33. Mistry H, Garnvwa H, Oppong R. Critical appraisal of published systematic reviews assessing the cost-effectiveness of telemedicine studies. Telemed J E Health 2014; 20:609-18.
34. Armfield NR, Edirippulige SK, Bradford N, Smith AC. Telemedicine-is the cart being put before the horse?. Med J Aust 2014; 200:530-3.
35. Centers for Medicare and Medicaid Services. Telemedicine. Available at: http://www.medicaid.gov/medicaid-chip-program-information/bytopics/delivery-systems/telemedicine.html. Accessed 10 November 2014.
36. Ontario Ministry of Health Annual Report. Embarkingon the journey for virtual care. Available at: https://otn.ca/sites/default/files/otnannual-report-2012-13.pdf. Accessed 10 November 2014.
37. Fragasso G, Cuko A, Spoladore R, et al. Validation of remote cardiopulmonary examination in patients with heart failure with a videophonebased system. J Card Fail 2007; 13:281-6.